Atopic Dermatitis

Can you identify atopic dermatitis phenotypes in children?
Can you identify atopic dermatitis phenotypes in children?In this slideshow, we summarize the phenotypes associated with childhood atopic dermatitis as addressed recently in JAMA Pediatrics.
Racial and ethnic disparities abound in eczema careEczema affects around 11% of children overall, but only about half of minority children with severe eczema are treated for the condition. A new study looks at why these children are overlooked.
In atopic dermatitis, are you employing the therapeutic ladder approach?Treatment for atopic dermatitis isn’t always straightforward. In this article, a physician outlines treatment approaches.
Atopic dermatitis: Biologics to watch in 2018In this article, we take a look at the development of new treatments for atopic dermatitis.
Manuka honey tested as AD treatmentA pilot study shows that Manuka honey may have some healing properties in atopic dermatitis.
An AD treatment phobia that is a “phenomenon”Atopic dermatitis patients have a phobia of topical corticosteroids that is so strong, it’s been described as a “phenomenon.”
Atopic dermatitis phenotypes may indicate outcomesChildren under two years old with signs of atopic dermatitis have an increased risk of developing asthma and food allergies, researchers report in JAMA Pediatrics. And, young children with both early onset atopic dermatitis and a food allergy, have a “very high risk” of developing asthma or allergic rhinitis.
Patch testing remains underreported
Patch testing remains underreportedPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.
Treatment updates for atopic dermatitis in childrenBecause the burden of atopic dermatitis in children is significant and can adversely impact a child’s normal socialization development, accurate diagnosis and effective treatment are vital.
Oral baricitinib instead of topicals for atopic dermatitis?EADV study shows that this JAK inhibitor is a promising drug candidate in moderate-to-severe AD.

Poll

View Results